The Role of the Gut Microbiota in Coronary Heart Disease.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 12, p. 1, doi. 10.1007/s11883-020-00892-2
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2020 AND VI 22 AND IP 12
Results: 7
1
2
Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 12, p. 1, doi. 10.1007/s11883-020-00891-3
- By:
- Publication type:
- Article
3
Highlights from Studies in Cardiovascular Disease Prevention Presented at the Digital 2020 European Society of Cardiology Congress: Prevention Is Alive and Well.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 12, p. N.PAG, doi. 10.1007/s11883-020-00895-z
- By:
- Publication type:
- Article
4
State of the Art in Noninvasive Imaging of Ischemic Heart Disease and Coronary Microvascular Dysfunction in Women: Indications, Performance, and Limitations.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 12, p. N.PAG, doi. 10.1007/s11883-020-00894-0
- By:
- Publication type:
- Article
5
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 12, p. N.PAG, doi. 10.1007/s11883-020-00893-1
- By:
- Publication type:
- Article
6
Digital Health Innovations to Improve Cardiovascular Disease Care.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 12, p. N.PAG, doi. 10.1007/s11883-020-00889-x
- By:
- Publication type:
- Article
7
Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 12, p. 1, doi. 10.1007/s11883-020-00890-4
- By:
- Publication type:
- Article